Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study reveals HPV vaccine gaps in teens with chronic illness

NCT ID NCT06158802

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how many girls and young women aged 11 to 20 with chronic diseases (like diabetes or immune conditions) got the HPV vaccine, compared to those without chronic illness. Researchers reviewed records of 223 participants from a hospital in France. The goal was to see if having a chronic condition affects vaccination rates and to find ways to improve vaccine access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

223 people

The number who actually took part.

Started

Jan 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged from 11 to 20 to cover the recommended age window for HPV vaccination, ie between 11 and 14 years old, with the possibility of catching up between 15 and 19 years of age (Public Health France, 2019). "Chronic condition" group: type 1 diabetes, metabolic diseases, immuno-hematological diseases, cystic fibrosis, sickle cell disease, kidney transplant, heart disease and inflammatory bowel disease, rare anorectal and pelvic malformations. Recruitment at the Necker-Enfants Malades Hospital and at the Specialized Medical Center for Children and Adolescents in Paris. "Control" group: patients in good health. Recruitment at the Specialized Medical Center for Children and Adolescents in Paris.

Ages

11 to 20 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Information and non-opposition of major patients and holders of parental authority of minor patients and minor patients * Girls and young women aged 11 to 20 * To be followed at the Necker-Enfants Malades Hospital ("chronic condition" group) * To be followed at the Specialized Medical Center for Children and Adolescents ("control" group) * Have a chronic condition ("chronic condition" group) : * Diabetes type 1 * Metabolic diseases * Patients followed in immuno-hematology * Cystic Fibrosis * Sickle * Kidney transplant * Heart Disease * Inflammatory bowel diseases * Rare anorectal and pelvic anomalies * Live in France * Comprehension of the French language (oral and written) Exclusion Criteria: * Have a contraindication to the HPV vaccine - Gardasil 9 (Vidal Hoptimal, 2018) * Have a contraindication to the HPV vaccine - Gardasil (Vidal Hopitmal, 2018) * Have a contraindication to HPV vaccine - Cervarix (Vidal Hoptimal, 2018)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic condition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorectal malformation Chronic Disease cystic fibrosis heart disorder inflammatory bowel disease metabolic disease sickle cell disease type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic condition Human papillomavirus vaccine

Contacts and locations

Locations

  • Centre Médical Spécialisé de l'Enfant et de l'Adolescent (CMSEA)

    Paris, 75011, France

  • Hôpital Necker-Enfants Malades

    Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.